Saturday 10 October 2026 Export all NVO data to Excel Powerpack

Novo Nordisk A/S

NVO Healthcare Drug Manufacturers General

Novo Nordisk A/S’s revenue for fiscal 2025 (year ended December 2025) was $46.8 billion, up 11.1% from fiscal 2024. In the quarter to June 2026, revenue grew 4.47%, EPS fell 18.7%, free cash flow grew 71.6% and total debt rose 44.4%, each against the same quarter a year earlier. Revenue growth for ten consecutive years, operating cash flow growth for five.

38.64 0.46 +1.20%

Follow NVO

Alert me

Market cap: $127.8B
P/E: 9.4×
Fwd P/E: —
Dividend yield: 4.65%
F-score: 5/9
Altman Z: 4.32
Beneish M: −2.51
Dividend safety: 46/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	11.72	8.63	14.66	16.13	+8 more quarters Free account
P/S ratio Full definition →	4.13	3.20	4.83	5.28
P/FCF ratio Full definition →	27.94	33.56	51.51	26.20
P/Operating CF Full definition →	24.83	43.28	393.97	32.83
P/B ratio Full definition →	6.18	5.13	7.69	9.27
Price to Tangible BV Full definition →	13.77	14.25	23.33	24.88
EV/Sales Full definition →	4.41	3.58	5.15	5.48
EV/EBITDA Full definition →	8.57	6.86	10.63	11.22
EV/Operating CF Full definition →	11.11	9.93	13.35	13.49
EV/FCF Full definition →	29.81	37.45	54.86	27.18
Quick Ratio Full definition →	0.66	0.56	0.57	0.57
Current Ratio Full definition →	0.87	0.79	0.80	0.78
Net Debt/EBITDA Full definition →	2.44	1.91	2.53	1.87
Debt/Assets Full definition →	23.55%	26.18%	24.12%	19.76%
Debt/Equity Full definition →	0.63	0.72	0.67	0.60
Asset Turnover Full definition →	0.62	0.65	0.63	0.67
Operating CF/Net income Full definition →	2.62	0.50	0.14	2.40
Capex/Depreciation Full definition →	(1.24)	(3.40)	(8.45)	(2.04)
Interest Coverage Full definition →	18.04	17.04	(22.99)	(15.50)
Research and Development Expense of Revenue Full definition →	22.66%	10.62%	18.11%	20.53%
Selling, General and Administrative Expense of Revenue Full definition →	20.78%	13.65%	21.87%	23.85%
Intangible Assets out of Total Assets Full definition →	0.21	0.23	0.24	0.21
Share Based Compensation of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Graham Net Nets Full definition →	(0.12)	(0.17)	(0.12)	(0.10)
Graham Number Full definition →	26.73	26.20	22.72	21.52
Earnings Yield Full definition →	8.53%	11.59%	6.82%	6.20%
Free Cash Flow Yield Full definition →	3.58%	2.98%	1.94%	3.82%
Revenue per Share Full definition →	2.75	3.41	2.78	2.64
Operating CF per Share Full definition →	1.93	0.85	0.13	1.69
Capex per Share Full definition →	(0.45)	(0.42)	(1.44)	(0.57)
Free Cash Flow per Share Full definition →	1.48	0.42	(1.31)	1.12
Cash per Share Full definition →	1.71	0.91	1.15	1.48
Shareholders Equity per Share Full definition →	7.76	7.16	6.61	5.98
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	7.76	7.16	6.61	5.98
Free Cash Flow Full definition →	6,585.08	1,886.25	(5,822.49)	4,961.69
Working Capital Full definition →	(4,728.22)	(7,491.90)	(6,541.70)	(8,217.58)
Capital Expenditures Full definition →	(1,979.80)	(1,885.31)	(6,396.29)	(2,552.86)
Net Current Asset Value Full definition →	(25,669.02)	(28,006.19)	(26,707.27)	(25,135.71)
EV/EBIT Full definition →	10.17	7.85	12.46	13.12
Capex to Sales Full definition →	0.16	0.12	0.52	0.22
Price to Operating Income Full definition →	9.53	7.04	11.70	12.64
Other line items
Average Receivables Full definition →	14,970.60	13,944.11	13,088.90	13,101.46
Average Payables Full definition →	3,280.25	2,540.16	3,587.02	3,646.31
Average Inventory Full definition →	7,467.02	7,044.14	6,718.01	6,516.04
Average Assets Full definition →	82,954.15	78,297.39	74,867.82	69,403.55
Average Common Equity Full definition →	29,996.77	25,673.99	25,092.09	22,185.33

Show all line items

Columns are period end dates

Stockrow Weekly